What is the IBC?
The National Institutes of Health require any organization that receives funding for recombinant DNA research to have an Institutional Biosafety Committee (IBC) to review and approve relevant projects. Further information can be found in the聽.
IBC Frequently Asked Questions
Any research project involving recombinant or synthetic DNA, microorganisms, biological toxins or venoms, materials from humans or non-human primates, or fieldwork with animals must be registered with the Institutional Biosafety Committee (IBC). Registration is also required for any research involving or that may be subject to
Yes. The NIH requires all relevant projects to be reviewed by the IBC regardless of their funding source.
Any work that falls under Section III-A, B, C, D or E of the , involves the use of infectious organisms included in , or the use of Biologically Active Toxins listed as will require review by the full committee.
If your research involves the use of or any activities subject to (DURC) regulations, you should contact Florida Atlantic鈥檚 Biosafety Officer before proceeding.
You can register with the IBC through the SciShield online platform (). If your SciShield account is not set up for biological research, please contact the office of Research Integrity. If you do not have a SciShield account, please contact EHS.
Clicking the blue button at the bottom of the Biological Summary Page and initialling each attestation will certify and submit your registration to the IBC for review. Only the PI can certify and submit registrations and any changes made to the registration after submission will not be reviewed until it has been recertified and resubmitted.
IBC registrations are approved for three years. Expiring registration must be resubmitted and re-reviewed.
IBC registrations can be amended through SciShield at any time. Changes will not be reviewed or approved until they have been certified and submitted by the PI.
At this time, 麻豆精品视频does not have the capability for BSL-3 work.
All laboratory staff handling or overseeing the handling of potentially biohazardous materials must be listed as personnel in an IBC registration.
All listed staff (including the PI) are required to have a current certificate for the CITI Initial Biosafety Training course. The PI for any project involving the handling of recombinant or synthetic DNA is required to have a current certificate for the CITI NIH Recombinant DNA Guidelines course. Additional training may be required for projects involving or activities subject to (DURC) regulations and further training may be required by EHS. Information about these courses can be found in the training section of the 麻豆精品视频IBC website. /research-admin/research-integrity/institutional-biosafety-committee/
The IRB has jurisdiction over research involving human subjects (participants), more information here.
Visit here for assistance in determining whether you need to submit an application to the IRB and if you are doing research involving human subjects.
Visit here for assistance in determining whether you need to submit an application to the IRB and if you are doing research involving human subjects.
Submissions to the IRB should be through IRB Novelution. Information on how to submit new projects, amendments, continuing reviews, and other IRB materials can be found here.
The IRB reviews projects based on risk. Per federal regulation, there are three types of IRB review: Exempt (less than minimal risk); Expedited (minimal risk); Full Review (greater than minimal risk). Only the Florida Atlantic IRB designated personnel can make the final determination on research risk can type of review.
It is important to note that exempt does not mean exempt from submission and review. Instead, it means exempt from federal regulations. Florida Atlantic policy requires .
It is important to note that Instead, it means that one member of the IRB committee will review the submission and that review at a fully convened meeting is not required.
It is important to note that exempt does not mean exempt from submission and review. Instead, it means exempt from federal regulations. Florida Atlantic policy requires .
It is important to note that Instead, it means that one member of the IRB committee will review the submission and that review at a fully convened meeting is not required.
The Principal Investigator (PI) must be a full time Florida Atlantic faculty/employee or otherwise eligible.
Yes, the PI does not have the authority to deem his/her proposal as exempt even if it meets all the criteria. All official approvals come from the IRB.
Exempt and expedited reviews are conducted on a rolling basis. There is no deadline for submitting these types of projects. Investigators who will conduct studies requiring review at a fully convened meeting should adhere to the submission schedule for these projects. If you are unsure whether your project requires review at a fully convened meeting, please contact the Florida Atlantic IRB for guidance.
For new protocols: the PI, Department Chair, and in some Colleges, the Dean's representative for research, must sign.If PI is also the Department Chair, then his/her Supervising Authority or the Dean's designee must sign off on the application before it is submitted to the IRB.
For continuing reviews: the PI and Department Chair must sign.
For responses to the IRB and amendments, only the PI must sign.
For adverse event and protocol violation reports, the PI and Department Chair must sign.
The assurance section at the bottom of each form tells you which signatures you need before submitting to the IRB. Please obtain ALL electronic signatures before submitting the IRB application.
For continuing reviews: the PI and Department Chair must sign.
For responses to the IRB and amendments, only the PI must sign.
For adverse event and protocol violation reports, the PI and Department Chair must sign.
The assurance section at the bottom of each form tells you which signatures you need before submitting to the IRB. Please obtain ALL electronic signatures before submitting the IRB application.
Please allow 4-6 weeks for the IRB to review and approve your application. You cannot start data collection involving human subjects until after the IRB approves your application.
No. You cannot start data collection involving human subjects until AFTER the IRB approves your submission.
You will receive a notice of approval to your IRB Novelution registered email. It is important to read that approval letter to understand any requirements or limitations of your approval. Other IRB approved materials such as consents may be accessed through IRB Novelution.
No. You can submit your proposal to the funding agency and list your IRB approval status as pending. With most federal agencies (NIH, NSF, Dept. of Education) you can submit the approval information "just in time" once you receive a fundable score, or when the agency requests the IRB approval information. However, don't wait too long to submit your IRB application because it can delay the funding agency's decision should you be selected to receive a grant. You should also consult the specific granting agency for its guidelines on the use of human subjects.
Florida Atlantic and most funding agencies will not release funding until IRB approval has been verified. Contact the Research Integrity office as soon as possible for assistance. We cannot issue an IRB approval immediately, but will work with your granting agency as needed to facilitate the award process.
Florida Atlantic's FWA # is FWA00000157.
If your protocol is, or will be funded by an outside organization, please note this on the IRB application. You will also need to submit the section of the grant or contract that describes your proposed scope of work with human subjects. Please ensure that the research described in your funding proposal matches the work described in the IRB application, and that the titles match. The IRB must ensure that the research it approves is consistent with what the sponsor is supporting.
No. The consent form is meant to inform participants about what is being asked of them in the simplest terms possible. Please do not copy and paste lengthy methodology from a protocol or grant application into the consent form. Ideally, the reading level of a consent form should be at a 6th - 8th grade reading level. Avoid scientific / technical terms and define or spell out all abbreviations and acronyms. Tip: always ask yourself what would you say if you were explaining your research study to a family member.
In Microsoft Word, there is a tool under Spelling and Grammar that provides a Flesch-Kincaid reading level score. Aim for a score of 8 or less.
No, not all studies required a signed written consent form. Choose the most appropriate consent process for your study. If you think your study does not require a signed consent, you must provide the IRB with a justification as to why this requirement should be waived.
Children cannot legally consent for themselves. Therefore, informing them about the study and asking them to agree to participate is called an assent process. Only parents or guardians can give consent for a child to participate in research, unless the IRB waives this requirement. However, even if a parent consents, if the child refuses to assent, the researcher generally should not enroll the child in his/her study.
In general, minors between ages 7 and 17 can give their written assent to participate in research. However, researchers sometimes write an assent document that contains long complex sentences and technical terms. An assent must be tailored to the emotional and educational level of the child. Short, simple sentences and friendly, conversational language is preferred. For very young children a verbal assent script that describes what will be said to the child may be more appropriate. It is also acceptable to not provide assent procedures if the child is extremely young or not capable of understanding (parental consent will still be needed).
Yes. If you plan to recruit subjects who do not speak English, you need to translate the written consent document to obtain true informed consent. However, since the IRB may request changes, please wait until after the IRB has approved the English version of the consent documents before seeking translation services. If you are using a verbal consent process, you still need to provide a translated version of the script that will be spoken to the participant.
All members of the research team must have CITI training certificates before a study can be approved. In short, anyone who will be involved in consenting, recruiting, or obtaining data from study participants must complete CITI Human Subjects Research training, unless it is already on file in the IRB office.
To register for CITI visit www.citiprogram.org. As a new user, you will need to click "Register Here" to register for the training course and select "麻豆精品视频" from the Participating Institutions. Do NOT sign up as an Independent Learner as you will incur a fee and will not be reimbursed. See the and adding courses.
At Florida Atlantic, CITI IRB training is valid for 3 years. After 3 years, you must complete a refresher course if you are still engaged in human subjects research at Florida Atlantic.
How quickly you complete CITI Training varies, but it will likely take you between 2 to 4 hours to complete all of the training modules. You do not have to complete the IRB training modules all at once. You may re-enter the site as often as necessary and complete the modules at your own pace.
You will need to score at least an 80% in order to pass the training course.
Yes, researchers accessing protected health information (PHI) will also be required to complete the CITI Information Privacy and Security (IPS).
Yes. Completion of the RCR Training Course from the CITI website does not satisfy the Florida Atlantic IRB Training requirement. All investigators conducting research involving human subjects must complete the CITI Human Subjects Research Course. Courses to choose from include: Biomedical Research Investigators, Social and Behavioral Research Investigators, and Data or Specimens Only Research.
No, you will not receive IRB approval if you have not completed the required IRB training.
Maybe. CITI Human Subjects Research Training is required for all non-Florida Atlantic researchers who are collaborating with Florida Atlantic researchers in conducting human subjects research, if Florida Atlantic will provide oversight for their role in the study. If the collaborator will be seeking IRB approval from their own institution for their role in the study, then Florida Atlantic has no oversight over the collaborator and they can use the training required by their home institution.
All CITI course offerings are on a three-year renewal cycle. This means that a refresher course will be due three years after you first complete a course. CITI will send you emails to remind you when a refresher course is due. It is important to adjust your email privacy settings so that you can receive these important emails.
A Data Use Agreement (DUA) is a contractual document used for the transfer of nonpublic data that is subject to restrictions on its use. For the guidance on Data Use Agreement please go here.
There is a distinction between research conducted by students and classroom research. Student research refers to human subjects research conducted by students in pursuit of an Honor's thesis, Master's thesis, dissertation, DIS, or other similar research. Student research projects should be submitted to the IRB and be actively monitored by the faculty advisor, who serves as Responsible Principal Investigator. Classroom research refers to students' involvement in course activities that are primarily intended to teach them how to conduct human subjects research, rather than contribute to generalizable knowledge. Results of these activities are generally not published or disseminated outside of an instructional setting. In most cases, classroom research does not need to be reviewed by the IRB. If at a later point, you decide to continue a class project as a research project, submit an IRB application for review and approval. More information can be found in the Toolkit for Researchers.
Anonymity means that an individual subject cannot be identified. No personal identifiers (e.g., name, signature, SS#, address, etc.) will be collected or associated with the data being used for research. Confidentiality means subjects' identities are known but will be protected to some extent by the investigator. For example: If you audiotape or videotape research subjects, their data is NOT anonymous, but you can take certain measures to ensure the data and recordings are kept confidential.
In addition to describing your recruitment plan in your protocol, don't forget to attach any advertising materials (flyers, scripts for radio or television ads, e-mail, texts, etc.) that will be used. Also, any incentives (money, extra credit, gift cards, etc.) that will be used to attract and retain participants should be described in your protocol and noted in any consent form(s) or procedures.
No. Due to Florida law, Florida Atlantic researchers are not able to use lotteries for prizes or cash as incentives for research participants.
If you are collecting data from persons at an institution outside of Florida Atlantic, or an outside institution is helping you with recruitment, you are working with cooperating institutions. The IRB requires a letter of cooperation from an appropriate person at that institution. The letter should be on institution letterhead and signed, however an email is sometimes acceptable if sufficient detail is provided. More information can be found in the Toolkit for Researchers.
Some agencies, such as county school districts, the Florida Department of Health, the Florida Department of Corrections, etc. may have their own separate research review processes. Please contact these agencies regarding their specific procedures. These agencies may require an additional review to ensure the study fits within their mission and is conducted according to their logistical or administrative processes. More information can be found in the Toolkit for Researchers.
It depends. If your research involves co-investigators at other sites who are enrolling subjects or collecting data, their institution may require them to undergo separate IRB approval. Please check to see if this is a requirement before submitting your IRB application. More information on collaborative agreements may be found in the Toolkit for Researchers.
Florida Atlantic鈥檚 Institutional Animal Care and Use Committee (IACUC) is composed of individuals dedicated to the humane care of animals used in research, teaching and testing and provides oversight and assistance in ensuring compliance to all laws, regulations, and policies governing the care and use of animals.
Any activity that involves the use of vertebrate animals or cephalopods in research, teaching and testing requires IACUC oversight, regardless of whether the activity is funded or not.
IACUC protocol applications and amendments to IACUC protocols using USDA Pain Category D and E procedures require full committee review and must be submitted to the IACUC office by the application deadline for consideration at the monthly IACUC meeting. The IACUC meeting dates and application deadlines are available on the Florida Atlantic IACUC website.
All other protocol applications and amendments using USDA Pain Category B and C procedures are eligible for the Designated Member Review process and may be submitted at any time.
All other protocol applications and amendments using USDA Pain Category B and C procedures are eligible for the Designated Member Review process and may be submitted at any time.
The latest version of the free Adobe Acrobat Reader DC must be installed on your computer in order to open the forms. The forms also work best when using Internet Explorer. If you are experiencing issues or prefer using Google Chrome or Firefox to access the forms, then please refer to the
All research personnel are required to complete a combination of on-line CITI courses, didactic session on the ethical and humane use of animals in research, teaching and testing, in-person hands-on workshops (applicable to rodent animal users only), and enrollment in Florida Atlantic鈥檚 medical monitoring program for animal research. The detailed list of training requirements is available in the training section of the Florida Atlantic IACUC website.
Please contact Dana Mulvaney (IACUC Coordinator) at dmulvane@fau.edu or Dr. Kristen Ware (Associate Director, Research Integrity) kcware@fau.edu.
An adverse event (AE) is an unexpected side effect associated with a study compound, experimental procedure, or new animal model (e.g., a new genetically modified strain). These events result in:
Injury or illness
Unrelieved pain or distress
Death of an animal enrolled in a research study
Injury or illness
Unrelieved pain or distress
Death of an animal enrolled in a research study
The Principal Investigator (PI) or their designee is responsible for reporting adverse events to the IACUC. Notify the AV and/or IACUC office as soon as possible after becoming aware of the event, preferably via email or phone. The AE report form must be submitted within 7 calendar days of the event.
In an emergency:
Immediately contact the AV for urgent medical intervention or guidance.
Inform the IACUC as soon as possible via email or phone.
Immediately contact the AV for urgent medical intervention or guidance.
Inform the IACUC as soon as possible via email or phone.
The report will be reviewed during the next IACUC meeting. The IACUC may:
Request clarification
Acknowledge and document the AE, closing the issue
Determine if further investigation is needed
Recommend or require additional actions to prevent recurrence of the AE
Request clarification
Acknowledge and document the AE, closing the issue
Determine if further investigation is needed
Recommend or require additional actions to prevent recurrence of the AE
Events that meet the following criteria do not need to be reported:
Injury or illness unrelated to the approved experimental procedures and are being treated by the AV.
Events that are described in the approved protocol and occur at or below the expected frequency stated in the protocol.
If you're unsure whether an event qualifies as an AE, please consult with the AV or IACUC office for guidance.
Injury or illness unrelated to the approved experimental procedures and are being treated by the AV.
Events that are described in the approved protocol and occur at or below the expected frequency stated in the protocol.
If you're unsure whether an event qualifies as an AE, please consult with the AV or IACUC office for guidance.
The HIPAA privacy rule sets forth policies to protect all individually identifiable health information that is held or transmitted. These are the 18 HIPAA Identifiers that are considered personally identifiable information. This information can be used to identify, contact, or locate a single person or can be used with other sources to identify a single individual. These identifiers are:
1. Name
2. Address (all geographic all geographic subdivisions smaller than state, including street address, city county, and zip code)
3. All elements (except years) of dates related to an individual (including birthdate, admission date, discharge date, date of death, and exact age if over 89)
4. Telephone numbers
5. Fax numbers
6. Email address
7. Social Security Number
8. Medical record number
9. Account number(s)
10. Health plan beneficiary number(s)
11. Certificate or license number(s)
12. Vehicle identifiers and serial numbers, including license plate numbers
13. Device identifiers and serial numbers
14. Web URL
15. Internet Protocol (IP) address
16. Finger of voice print
17. Photographic image (not limited to face)
18. Any other characteristic that could uniquely identify the individual
1. Name
2. Address (all geographic all geographic subdivisions smaller than state, including street address, city county, and zip code)
3. All elements (except years) of dates related to an individual (including birthdate, admission date, discharge date, date of death, and exact age if over 89)
4. Telephone numbers
5. Fax numbers
6. Email address
7. Social Security Number
8. Medical record number
9. Account number(s)
10. Health plan beneficiary number(s)
11. Certificate or license number(s)
12. Vehicle identifiers and serial numbers, including license plate numbers
13. Device identifiers and serial numbers
14. Web URL
15. Internet Protocol (IP) address
16. Finger of voice print
17. Photographic image (not limited to face)
18. Any other characteristic that could uniquely identify the individual
The process of de-identification, by which identifiers are removed from the health information, mitigates privacy risks to individuals and thereby supports the secondary use of data for comparative effectiveness studies, policy assessment, life sciences research, and other endeavors. If a communication contains any of the 18 HIPAA identifiers, or parts of the identifier, such as initials, the data is to be considered 鈥渋dentified鈥�. To be considered 鈥渄e-identified鈥�, all of the HIPAA Identifiers must be removed from the data set. This includes all dates, such as surgery dates, all voice recordings, and all photographic images.
The Privacy Rule provides two de-identification methods: 1) a formal determination by a qualified expert; or 2) the removal of specified individual identifiers as well as absence of actual knowledge by the covered entity that the remaining information could be used alone or in combination with other information to identify the individual.
The Privacy Rule provides two de-identification methods: 1) a formal determination by a qualified expert; or 2) the removal of specified individual identifiers as well as absence of actual knowledge by the covered entity that the remaining information could be used alone or in combination with other information to identify the individual.
A 鈥渓imited data set鈥� (LDS) is a limited set of identifiable patient information as defined in HIPAA. A 鈥渓imited data set鈥� of information may be disclosed to an outside party without a patient鈥檚 authorization if certain conditions are met. First, the purpose of the disclosure may only be for research, public health or health care operations. Second, the person receiving the information must sign a data use agreement.
A LDS is information from which 鈥渇acial鈥� identifiers have been removed. Specifically, as it relates to the individual or his or her relatives, employers or household members, all the following identifiers must be removed in order for health information to be LDS
鈥� Names;
鈥� Street addresses (other than town, city, state and zip code);
鈥� Telephone numbers;
鈥� Fax numbers;
鈥� Email addresses;
鈥� Social Security numbers;
鈥� Medical records numbers;
鈥� Health plan beneficiary numbers;
鈥� Account numbers;
鈥� Certificate license numbers;
鈥� Vehicle identifiers and serial numbers, including license plates;
鈥� Device identifiers and serial numbers;
鈥� URLs;
鈥� IP address numbers;
鈥� Biometric identifiers (including finger and voice prints); and
鈥� Full face photos (or comparable images).
The health information that may remain in the information disclosed includes:
鈥� Dates such as admission, discharge, service, birth, death;
鈥� City, state, five digit or more zip code; and
鈥� Ages in years, months or days or hours.
It is important to note that this information is still PHI under HIPAA. It is not de-identified information and is still subject to the requirements of the Privacy Regulations.
鈥� Names;
鈥� Street addresses (other than town, city, state and zip code);
鈥� Telephone numbers;
鈥� Fax numbers;
鈥� Email addresses;
鈥� Social Security numbers;
鈥� Medical records numbers;
鈥� Health plan beneficiary numbers;
鈥� Account numbers;
鈥� Certificate license numbers;
鈥� Vehicle identifiers and serial numbers, including license plates;
鈥� Device identifiers and serial numbers;
鈥� URLs;
鈥� IP address numbers;
鈥� Biometric identifiers (including finger and voice prints); and
鈥� Full face photos (or comparable images).
The health information that may remain in the information disclosed includes:
鈥� Dates such as admission, discharge, service, birth, death;
鈥� City, state, five digit or more zip code; and
鈥� Ages in years, months or days or hours.
It is important to note that this information is still PHI under HIPAA. It is not de-identified information and is still subject to the requirements of the Privacy Regulations.
Because LDS is still PHI, the Privacy Regulations contemplate that the privacy of individuals will be protected by requiring covered entities to enter into data use agreements (DUA) with recipients of LDS. The data use agreement must meet standards specified in the Privacy Regulations. A DUA must:
鈥� Establish the permitted uses and disclosures of the limited data set;
鈥� Identify who may use or receive the information;
鈥� Prohibit the recipient from using or further disclosing the information, except as permitted by the agreement or as permitted by law;
鈥� Require the recipient to use appropriate safeguards to prevent a use or disclosure that is not permitted by the agreement;
鈥� Require the recipient to report to the covered entity any unauthorized use or disclosure of which it becomes aware;
鈥� Require the recipient to ensure that any agents (including a subcontractor) to whom it provides the information will agree to the same restrictions as provided in the agreement; and
鈥� Prohibit the recipient from identifying the information or contacting the individuals.
If receiving data from an external covered entity, the DUA accompanied by the list of requested data from the medical record must be submitted to the IRB as part of the related research protocol review and approval.
鈥� Establish the permitted uses and disclosures of the limited data set;
鈥� Identify who may use or receive the information;
鈥� Prohibit the recipient from using or further disclosing the information, except as permitted by the agreement or as permitted by law;
鈥� Require the recipient to use appropriate safeguards to prevent a use or disclosure that is not permitted by the agreement;
鈥� Require the recipient to report to the covered entity any unauthorized use or disclosure of which it becomes aware;
鈥� Require the recipient to ensure that any agents (including a subcontractor) to whom it provides the information will agree to the same restrictions as provided in the agreement; and
鈥� Prohibit the recipient from identifying the information or contacting the individuals.
If receiving data from an external covered entity, the DUA accompanied by the list of requested data from the medical record must be submitted to the IRB as part of the related research protocol review and approval.
A financial conflict of interest exists when an investigator's significant financial interest could affect the design, conduct, or reporting of research. Any potential financial conflict of interest must be managed in order to ensure the integrity of the research, the safety of any research participants, and the proper development of any intellectual property.
A Significant Financial Interest includes any entity where the researcher's equity and remuneration combined exceed $5000, any non-publicly traded entity in which the researcher has any equity, or any intellectual property, patents, or copyrights. The SFI can be updated in Novelution at any time. More information can be found in the
You must disclose Significant Financial Interests for:
鈥� Yourself
鈥� Your spouse
鈥� Your dependent children
鈥� Yourself
鈥� Your spouse
鈥� Your dependent children
SFI disclosures should be updated:
鈥� Annually
鈥� Prior to submitting proposals for internal or external funding
鈥� Within 30 days of acquiring a new SFI
鈥� Within 30 days of joining a research project already in progress
鈥� Within 30 days of any reimbursed or sponsored travel
鈥� Annually
鈥� Prior to submitting proposals for internal or external funding
鈥� Within 30 days of acquiring a new SFI
鈥� Within 30 days of joining a research project already in progress
鈥� Within 30 days of any reimbursed or sponsored travel
Significant Financial Interest does NOT include:
鈥� remuneration from FAU
鈥� remuneration paid to a researcher鈥檚 family by any entity that would not reasonably appear to be related to any area of the investigator鈥檚 institutional responsibilities
鈥� remuneration from authorship of academic or scholarly works
鈥� remuneration from seminars, lectures, or teaching engagements sponsored by governmental agencies or institutions of higher education within the U.S.
鈥� investment by a mutual fund, pension fund or other investment fund where the researcher does not control investment decisions
鈥� remuneration from FAU
鈥� remuneration paid to a researcher鈥檚 family by any entity that would not reasonably appear to be related to any area of the investigator鈥檚 institutional responsibilities
鈥� remuneration from authorship of academic or scholarly works
鈥� remuneration from seminars, lectures, or teaching engagements sponsored by governmental agencies or institutions of higher education within the U.S.
鈥� investment by a mutual fund, pension fund or other investment fund where the researcher does not control investment decisions
Novelution will prompt researchers who have disclosed outside interests in an SFI disclosure to complete a PSD when a sponsored research project in which they are key personnel is funded. A PSD must be completed for each project individually. This disclosure must be submitted and reviewed before funds can be released.
The PSD should serve as a record of all information required by the FCOI Committee to make an independent determination as to the potential for a financial conflict of interest. Please address the following questions for each outside interest:
鈥� What is the goal of your outside interest?
鈥� What is your role in the outside interest?
鈥� What is the goal of your sponsored research project?
鈥� What is your role in the sponsored research project?
鈥� Describe any way that your outside interest is directly related to your sponsored research project.
鈥� Describe how the goals of your outside interest and the goals of your sponsored research project do or do not indirectly overlap or conflict.
鈥� Describe any steps you have taken to ensure the objectivity and integrity of your research given your outside interest.
A financial conflict of interest can still exist when the outside financial interest is not directly related in the research project. Describe the goals of the research projecty and the goals of the outside interest in full in each PSD.
鈥� What is the goal of your outside interest?
鈥� What is your role in the outside interest?
鈥� What is the goal of your sponsored research project?
鈥� What is your role in the sponsored research project?
鈥� Describe any way that your outside interest is directly related to your sponsored research project.
鈥� Describe how the goals of your outside interest and the goals of your sponsored research project do or do not indirectly overlap or conflict.
鈥� Describe any steps you have taken to ensure the objectivity and integrity of your research given your outside interest.
A financial conflict of interest can still exist when the outside financial interest is not directly related in the research project. Describe the goals of the research projecty and the goals of the outside interest in full in each PSD.